Bosun Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$587K Hold
2,400
0.32% 39
2025
Q4
$497K Hold
2,400
0.24% 42
2025
Q3
$445K Sell
2,400
-1
-0% -$171 0.23% 41
2025
Q2
$367K Sell
2,401
-293
-11% -$45K 0.11% 159
2025
Q1
$447K Buy
2,694
+293
+12% +$45.8K 0.19% 128
2024
Q4
$347K Sell
2,401
-966
-29% -$150K 0.15% 151
2024
Q3
$546K Sell
3,367
-134
-4% -$21.4K 0.26% 110
2024
Q2
$512K Sell
3,501
-386
-10% -$57.4K 0.3% 88
2024
Q1
$615K Sell
3,887
-57
-1% -$9.07K 0.35% 100
2023
Q4
$618K Buy
3,944
+321
+9% +$49.2K 0.61% 46
2023
Q3
$564K Sell
3,623
-4,922
-58% -$812K 0.61% 47
2023
Q2
$1.41M Buy
8,545
+151
+2% +$24.4K 1.39% 12
2023
Q1
$1.3M Buy
8,394
+3,597
+75% +$581K 1.48% 10
2022
Q4
$847K Buy
4,797
+697
+17% +$120K 1.2% 12
2022
Q3
$670K Sell
4,100
-1,508
-27% -$255K 1.04% 18
2022
Q2
$995K Buy
5,608
+1,120
+25% +$200K 1.37% 13
2022
Q1
$795K Buy
4,488
+202
+5% +$34.4K 0.84% 21
2021
Q4
$733K Buy
+4,286
New +$702K 0.67% 22

Other funds holding JNJ

Bosun Asset Management's JNJ Position: Q1 2026 in Review

Bosun Asset Management held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 2,400 shares worth $587K. The position accounts for 0.32% of the portfolio, ranked #39.

Bosun Asset Management first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.41M in Q2 2023. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bosun Asset Management held 2,400 shares of Johnson & Johnson worth $587K as of Q1 2026.
  • Bosun Asset Management left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.32% of Bosun Asset Management's portfolio in Q1 2026, its #39 holding.
  • Bosun Asset Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Bosun Asset Management's Johnson & Johnson position peaked at $1.41M in Q2 2023.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bosun Asset Management's 13F filing for Q1 2026, filed 11 May 2026.